Microarchitecture, the key to bone quality.
暂无分享,去创建一个
[1] R. Rizzoli,et al. Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats , 2005, Osteoporosis International.
[2] R. Rizzoli,et al. The New Selective Estrogen Receptor Modulator MDL 103,323 Increases Bone Mineral Density and Bone Strength in Adult Ovariectomized Rats , 1999, Osteoporosis International.
[3] H. Blair,et al. Recent advances in osteoclast biology and pathological bone resorption. , 2004, Histology and histopathology.
[4] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[5] David L. Lacey,et al. Osteoclast differentiation and activation , 2003, Nature.
[6] L. Palermo,et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. , 2005, The New England journal of medicine.
[7] Daniel Chappard,et al. Trabecular bone microarchitecture: a review. , 2008, Morphologie : bulletin de l'Association des anatomistes.
[8] Jessica D. Kaufman,et al. Nanomechanical analysis of bone tissue engineering scaffolds. , 2007, Journal of biomedical materials research. Part A.
[9] B. Clarke,et al. Osteoporosis: Etiology, diagnosis, and management, 2nd ed Edited by B. Lawrence Riggs, M.D. and L. Joseph Melton, M.D., III. Philadelphia, Lippincott-Raven Publishers, 1995, $125.00 (xv + 542 pages), ISBN 0-7817-0275-5 , 1996, Trends in Endocrinology & Metabolism.
[10] A. Hofman,et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. , 2004, Bone.
[11] Y. Ubara,et al. Histomorphometric features of bone in patients with primary and secondary hypoparathyroidism. , 2003, Kidney international.
[12] Johan R de Jong,et al. A comparison of micro-CT, microradiography and histomorphometry in bone research. , 2008, Archives of oral biology.
[13] B. Troen. Molecular mechanisms underlying osteoclast formation and activation , 2003, Experimental Gerontology.
[14] B. Lawrence Riggs,et al. Osteoporosis : etiology, diagnosis, and management , 1988 .
[15] H Sievänen,et al. Exercise-induced bone gain is due to enlargement in bone size without a change in volumetric bone density: a peripheral quantitative computed tomography study of the upper arms of male tennis players. , 2000, Bone.
[16] E. Eriksen,et al. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. , 1986, Endocrine reviews.
[17] G. Pharr,et al. Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation. , 1997, Biomaterials.
[18] S. Cummings,et al. How drugs decrease fracture risk: lessons from trials. , 2002, Journal of musculoskeletal & neuronal interactions.
[19] J. Shapter,et al. Micromechanical properties of human trabecular bone: a hierarchical investigation using nanoindentation. , 2008, Journal of biomedical materials research. Part A.
[20] Mary L Bouxsein,et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.
[21] H. K. Genant,et al. Advanced CT bone imaging in osteoporosis , 2008, Rheumatology.
[22] Mary L Bouxsein,et al. Determinants of skeletal fragility. , 2005, Best practice & research. Clinical rheumatology.
[23] R. Lindsay,et al. Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts , 2005, Journal of cellular biochemistry.
[24] S. Yamada,et al. Menopause-related changes in bone mineral density in Japanese women: A longitudinal study on lumbar spine and proximal femur , 2004, Calcified Tissue International.
[25] S. Goldstein,et al. Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur. , 1999, Journal of biomechanics.
[26] M. Bouxsein. Technology Insight: noninvasive assessment of bone strength in osteoporosis , 2008, Nature Clinical Practice Rheumatology.
[27] G D Roodman,et al. Cell biology of the osteoclast. , 1999, Experimental hematology.
[28] F. Coe,et al. Disorders of bone and mineral metabolism , 1992 .
[29] K. Takaoka,et al. Trabecular minimodeling in human iliac bone. , 2003, Bone.
[30] Ego Seeman,et al. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. , 2004, Bone.
[31] G. Cook,et al. Primer on the metabolic bone diseases and disorders of mineral metabolism , 2003 .
[32] D. Dempster,et al. Anatomy and functions of the adult skeleton , 2006 .
[33] Mathieu Charlebois,et al. Validation of a voxel-based FE method for prediction of the uniaxial apparent modulus of human trabecular bone using macroscopic mechanical tests and nanoindentation. , 2007, Journal of biomechanics.
[34] E. Barrett-Connor,et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. , 2004, Archives of internal medicine.
[35] P. Geusens,et al. Relationship Between Changes in BMD and Nonvertebral Fracture Incidence Associated With Risedronate: Reduction in Risk of Nonvertebral Fracture Is Not Related to Change in BMD , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] S. Reddy. Regulatory mechanisms operative in osteoclasts. , 2004, Critical reviews in eukaryotic gene expression.
[37] P. Zysset,et al. Morphological and Mechanical Properties of Bone Structural Units: A Two-Case Study , 2002 .
[38] H. Genant,et al. Advanced imaging of bone macrostructure and microstructure in bone fragility and fracture repair. , 2008, The Journal of bone and joint surgery. American volume.
[39] H. Anderson. Matrix vesicles and calcification , 2003, Current rheumatology reports.
[40] R. Turner,et al. Histological analysis of bone. , 2008, Methods in molecular biology.
[41] Y. Ubara,et al. Significance of minimodeling in dialysis patients with adynamic bone disease. , 2005, Kidney international.